Johnson, V.E., W. Stewart, and D.H. Smith. 2013. Axonal pathology in traumatic brain injury. Experimental Neurology 246: 35–43. https://doi.org/10.1016/j.expneurol.2012.01.013.
CAS Article PubMed Google Scholar
Russo, M.V., and D.B. McGavern. 2016. Inflammatory neuroprotection following traumatic brain injury. Science 353: 783–785. https://doi.org/10.1126/science.aaf6260.
CAS Article PubMed PubMed Central Google Scholar
Chiu, C.C., Y.E. Liao, L.Y. Yang, J.Y. Wang, D. Tweedie, H.K. Karnati, N.H. Greig, and J.Y. Wang. 2016. Neuroinflammation in animal models of traumatic brain injury. Journal of Neuroscience Methods 272: 38–49. https://doi.org/10.1016/j.jneumeth.2016.06.018.
Article PubMed PubMed Central Google Scholar
Dash, H.H., and S. Chavali. 2018. Management of traumatic brain injury patients. Korean Journal of Anesthesiology 71: 12–21. https://doi.org/10.4097/kjae.2018.71.1.12.
Article PubMed PubMed Central Google Scholar
Forstner, P., R. Rehman, S. Anastasiadou, M. Haffner-Luntzer, D. Sinske, A. Ignatius, F. Roselli, and B. Knoll. 2018. Neuroinflammation after traumatic brain injury is enhanced in activating transcription factor 3 mutant mice. Journal of Neurotrauma 35: 2317–2329. https://doi.org/10.1089/neu.2017.5593.
Conductier, G., N. Blondeau, A. Guyon, J.L. Nahon, and C. Rovere. 2010. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. Journal of Neuroimmunology 224: 93–100. https://doi.org/10.1016/j.jneuroim.2010.05.010.
CAS Article PubMed Google Scholar
Murugan, M., A. Ravula, A. Gandhi, G. Vegunta, S. Mukkamalla, W. Mujib, and N. Chandra. 2020. Chemokine signaling mediated monocyte infiltration affects anxiety-like behavior following blast injury. Brain, Behavior, and Immunity 88: 340–352. https://doi.org/10.1016/j.bbi.2020.03.029.
CAS Article PubMed Google Scholar
Kumar, A., and D.J. Loane. 2012. Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention. Brain, Behavior, and Immunity 26: 1191–1201. https://doi.org/10.1016/j.bbi.2012.06.008.
Semple, B.D., N. Bye, M. Rancan, J.M. Ziebell, and M.C. Morganti-Kossmann. 2010. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): Evidence from severe TBI patients and CCL2-/- mice. Journal of Cerebral Blood Flow and Metabolism 30: 769–782. https://doi.org/10.1038/jcbfm.2009.262.
Wang, Y., Y. Wei, S. Oguntayo, D. Wilder, L. Tong, Y. Su, I. Gist, P. Arun, and J.B. Long. 2017. Cerebrospinal fluid chemokine (C-C motif) ligand 2 is an early-response biomarker for blast-overpressure-wave-induced neurotrauma in rats. Journal of Neurotrauma 34: 952–962. https://doi.org/10.1089/neu.2016.4465.
Redell, J.B., A.N. Moore, R.J. Grill, D. Johnson, J. Zhao, Y. Liu, and P.K. 2013. Dash, Analysis of functional pathways altered after mild traumatic brain injury. Journal of Neurotrauma 30: 752–764. https://doi.org/10.1089/neu.2012.2437.
Article PubMed PubMed Central Google Scholar
Cao, L., and J.T. Malon. 2018. Anti-nociceptive role of CXCL1 in a murine model of peripheral nerve injury-induced neuropathic pain. Neuroscience 372: 225–236. https://doi.org/10.1016/j.neuroscience.2017.12.048.
CAS Article PubMed Google Scholar
Huang, H., A. Xia, L. Sun, C. Lu, Y. Liu, Z. Zhu, S. Wang, J. Cai, X. Zhou, and S. Liu. 2021. Pathogenic functions of tumor necrosis factor receptor-associated factor 6 signaling following traumatic brain injury. Frontiers in Molecular Neuroscience 14: 629910. https://doi.org/10.3389/fnmol.2021.629910.
CAS Article PubMed PubMed Central Google Scholar
Liu, S., L. Zhang, Q. Wu, Q. Wu, and T. Wang. 2013. Chemokine CCL2 induces apoptosis in cortex following traumatic brain injury. Journal of Molecular Neuroscience 51: 1021–1029. https://doi.org/10.1007/s12031-013-0091-8.
CAS Article PubMed Google Scholar
Gyoneva, S., and R.M. Ransohoff. 2015. Inflammatory reaction after traumatic brain injury: Therapeutic potential of targeting cell-cell communication by chemokines. Trends in Pharmacological Sciences 36: 471–480. https://doi.org/10.1016/j.tips.2015.04.003.
CAS Article PubMed PubMed Central Google Scholar
Liba, Z., H. Nohejlova, V. Capek, P. Krsek, A. Sediva, and J. Kayserova. 2019. Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers. PLoS ONE 14: e0219987. https://doi.org/10.1371/journal.pone.0219987.
CAS Article PubMed PubMed Central Google Scholar
Maric, L.S., S.Z. Lepej, L. Gorenec, I. Grgic, V. Trkulja, O.D. Rode, S. Roglic, T. Grmoja, N. Barisic, and G. Tesovic. 2018. Chemokines CXCL10, CXCL11, and CXCL13 in acute disseminated encephalomyelitis, non-polio enterovirus aseptic meningitis, and neuroborreliosis: CXCL10 as initial discriminator in diagnostic algorithm? Neurological Sciences 39: 471–479. https://doi.org/10.1007/s10072-017-3227-8.
Karve, I.P., J.M. Taylor, and P.J. Crack. 2016. The contribution of astrocytes and microglia to traumatic brain injury. British Journal of Pharmacology 173: 692–702. https://doi.org/10.1111/bph.13125.
CAS Article PubMed Google Scholar
Mousessian, A.S., C.P. Nunes da Silva, S.M. Oba-Shinjo, A.G. Kolias, W.S. Paiva, and S.K. Nagahashi Marie. 2021. CXCR7, CXCR4, and their ligand expression profile in traumatic brain injury. World Neurosurg 147: e16–e24. https://doi.org/10.1016/j.wneu.2020.11.022.
Shen, L.J., J. Zhou, C.S. Yang, Q.W. Lv, and Q.C. Xu. 2020. Serum CXC chemokine ligand-12 as a potential predictor for in-hospital major adverse events after severe traumatic brain injury. Clinica Chimica Acta 509: 244–248. https://doi.org/10.1016/j.cca.2020.06.031.
Kumar, A., R.J. Henry, B.A. Stoica, D.J. Loane, G. Abulwerdi, S.A. Bhat, and A.I. Faden. 2019. Neutral sphingomyelinase inhibition alleviates LPS-induced microglia activation and neuroinflammation after experimental traumatic brain injury. Journal of Pharmacology and Experimental Therapeutics 368: 338–352. https://doi.org/10.1124/jpet.118.253955.
CAS Article PubMed PubMed Central Google Scholar
Dalgard, C.L., J.T. Cole, W.S. Kean, J.J. Lucky, G. Sukumar, D.C. McMullen, H.B. Pollard, and W.D. Watson. 2012. The cytokine temporal profile in rat cortex after controlled cortical impact. Frontiers in Molecular Neuroscience 5: 6. https://doi.org/10.3389/fnmol.2012.00006.
CAS Article PubMed PubMed Central Google Scholar
Dyhrfort, P., Q. Shen, F. Clausen, M. Thulin, P. Enblad, M. Kamali-Moghaddam, A. Lewen, and L. Hillered. 2019. Monitoring of protein biomarkers of inflammation in human traumatic brain injury using microdialysis and proximity extension assay technology in neurointensive care. Journal of Neurotrauma 36: 2872–2885. https://doi.org/10.1089/neu.2018.6320.
Article PubMed PubMed Central Google Scholar
Begum, G., R. Reddy, K.M. Yakoub, A. Belli, D.J. Davies, and V. Di Pietro. 2020. Differential Expression of Circulating Inflammatory Proteins Following Sport-Related Traumatic Brain Injury. International Journal of Molecular Sciences 21: undefined. https://doi.org/10.3390/ijms21041216.
Popiolek-Barczyk, K., A. Ciechanowska, K. Ciapała, K. Pawlik, M. Oggioni, D. Mercurio, M.G. De Simoni, and J. Mika. 2020. The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia. Molecular and Cellular Probes 54: 101671. https://doi.org/10.1016/j.mcp.2020.101671.
CAS Article PubMed Google Scholar
Liu, R., X.Y. Liao, J.C. Tang, M.X. Pan, S.F. Chen, P.X. Lu, L.J. Lu, Z.F. Zhang, Y.Y. Zou, L.H. Bu, X.P. Qin, and Q. Wan. 2019. BpV(pic) confers neuroprotection by inhibiting M1 microglial polarization and MCP-1 expression in rat traumatic brain injury. Molecular Immunology 112: 30–39. https://doi.org/10.1016/j.molimm.2019.04.010.
CAS Article PubMed Google Scholar
Ho, L., W. Zhao, K. Dams-O’Connor, C.Y. Tang, W. Gordon, E.R. Peskind, S. Yemul, V. Haroutunian, and G.M. Pasinetti. 2012. Elevated plasma MCP-1 concentration following traumatic brain injury as a potential “predisposition” factor associated with an increased risk for subsequent development of Alzheimer’s disease. Journal of Alzheimer’s Disease 31: 301–313. https://doi.org/10.3233/JAD-2012-120598.
Szmydynger-Chodobska, J., N. Strazielle, J.R. Gandy, T.H. Keefe, B.J. Zink, J.F. Ghersi-Egea, and A. Chodobski. 2012. Posttraumatic invasion of monocytes across the blood-cerebrospinal fluid barrier. Journal of Cerebral Blood Flow and Metabolism 32: 93–104. https://doi.org/10.1038/jcbfm.2011.111.
CAS Article PubMed Google Scholar
Rowland, B., J.P.J. Savarraj, J. Karri, X. Zhang, J. Cardenas, H.A. Choi, J.B. Holcomb, and C.E. Wade. 2020. Acute inflammation in traumatic brain injury and polytrauma patients using network analysis. Shock 53: 24–34. https://doi.org/10.1097/SHK.0000000000001349.
Article PubMed PubMed Central Google Scholar
Israelsson, C., A. Kylberg, H. Bengtsson, L. Hillered, and T. Ebendal. 2014. Interacting chemokine signals regulate dendritic cells in acute brain injury. PLoS ONE 9: e104754. https://doi.org/10.1371/journal.pone.0104754.
CAS Article PubMed PubMed Central Google Scholar
Geiger, E.V., M. Maier, S. Schiessling, S. Wutzler, M. Lehnert, I. Marzi, and D. Henrich. 2013. Subsequent gene expression pattern in dendritic cells following multiple trauma. Langenbeck’s Archives of Surgery 398: 327–333. https://doi.org/10.1007/s00423-012-1031-8.
Yokobori, S., K. Hosein, S. Burks, I. Sharma, S. Gajavelli, and R. Bullock. 2013. Biomarkers for the clinical differential diagnosis in traumatic brain injury–a systematic review. CNS Neuroscience & Therapeutics 19: 556–565. https://doi.org/10.1111/cns.12127.
留言 (0)